Skip to main content
TipRanks
Go Ultimate75% OFF

Jack Nathan Medical (JNH) Ratios

13 Followers

Jack Nathan Medical Ratios

TSE:JNH's free cash flow for Q1 2026 was C$-1.13M. For the 2026 fiscal year, TSE:JNH's free cash flow was decreased by C$-5.00 and operating cash flow was C$-1.13M. See a summary of the company’s cash flow.

Financial ratios
RatiosApr 25Jan 24Apr 23Apr 22Apr 21
Liquidity Ratios
Current Ratio1.810.910.458.4923.67
Quick Ratio1.810.910.458.6150.46
Cash Ratio1.270.490.268.0123.67
Solvency Ratio3.75-0.32-0.72-3.42-567.86
Operating Cash Flow Ratio-3.69-0.97-0.36-0.84-3.87
Short-Term Operating Cash Flow Coverage-108.17-3.04-0.94-4.03-0.32
Net Current Asset ValueC$ 912.15KC$ -11.38MC$ -5.80MC$ 6.02MC$ 389.59K
Leverage Ratios
Debt-to-Assets Ratio0.071.110.710.071.75
Debt-to-Equity Ratio0.18-2.08-2.440.081.83
Debt-to-Capital Ratio0.161.921.700.080.65
Long-Term Debt-to-Capital Ratio0.002.54-8.240.010.32
Financial Leverage Ratio2.68-1.88-3.451.251.04
Debt Service Coverage Ratio-12.71-2.06-2.14-19.13-39.53
Interest Coverage Ratio-39.030.00-12.95-41.29-37.39
Debt to Market Cap0.013.450.560.020.01
Interest Debt Per Share0.000.140.060.010.01
Net Debt to EBITDA1.27-1.88-0.560.93-0.03
Profitability Margins
Gross Profit Margin84.66%75.62%76.31%71.84%97.20%
EBIT Margin-27.45%-32.04%-42.48%-83.54%-266.30%
EBITDA Margin-17.68%-25.88%-35.57%-78.17%-262.54%
Operating Profit Margin-28.48%-33.66%-34.25%-77.89%-35.18%
Pretax Profit Margin-28.88%-38.87%-45.13%-85.41%-267.26%
Net Profit Margin85.74%-34.66%-45.69%-81.00%-257.09%
Continuous Operations Profit Margin-29.06%-34.66%-44.57%-83.16%-257.37%
Net Income Per EBT-296.92%89.17%101.26%94.84%96.19%
EBT Per EBIT101.39%115.49%131.74%109.66%759.78%
Return on Assets (ROA)210.68%-59.32%-109.70%-73.30%-2434.50%
Return on Equity (ROE)563.81%111.59%378.90%-91.50%-2541.88%
Return on Capital Employed (ROCE)-136.45%-131.62%-632.28%-77.47%-347.80%
Return on Invested Capital (ROIC)-128.16%-80.01%-159.45%-71.67%-41.66%
Return on Tangible Assets210.68%-64.75%-137.20%-82.27%1313.99%
Earnings Yield100.00%-193.96%-104.94%-47.48%-23.11%
Efficiency Ratios
Receivables Turnover15.667.6617.3410.9713.85
Payables Turnover0.801.171.171.490.15
Inventory Turnover0.000.000.00-23.64-0.24
Fixed Asset Turnover21.144.336.067.833.13
Asset Turnover2.461.712.400.909.47
Working Capital Turnover Ratio20.17-10.527.572.54-5.49
Cash Conversion Cycle-432.38-265.52-292.24-226.46-3956.27
Days of Sales Outstanding23.3047.6621.0433.2926.36
Days of Inventory Outstanding0.000.000.00-15.44-1552.87
Days of Payables Outstanding455.68313.18313.29244.302429.76
Operating Cycle23.3047.6621.0417.85-1526.51
Cash Flow Ratios
Operating Cash Flow Per Share-0.03-0.07-0.02-0.01-0.00
Free Cash Flow Per Share-0.03-0.12-0.05-0.02-0.01
Dividend Paid and CapEx Coverage Ratio-5.40-1.49-0.78-1.62-0.13
Capital Expenditure Coverage Ratio-5.40-1.49-0.78-1.62-0.13
Operating Cash Flow Coverage Ratio-26.15-0.49-0.44-1.13-0.09
Operating Cash Flow to Sales Ratio-0.73-0.32-0.13-0.08-0.02
Free Cash Flow Yield-101.03%-298.05%-68.08%-7.96%-1.32%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-1.03-0.52-0.95-2.11-4.33
Price-to-Sales (P/S) Ratio0.860.180.441.7111.12
Price-to-Book (P/B) Ratio5.64-0.58-3.611.93109.99
Price-to-Free Cash Flow (P/FCF) Ratio-0.99-0.34-1.47-12.56-75.67
Price-to-Operating Cash Flow Ratio-1.17-0.56-3.36-20.32-644.05
Price-to-Earnings Growth (PEG) Ratio0.020.070.080.04-0.09
Enterprise Value Multiple-3.58-2.57-1.78-1.26-4.27
Enterprise Value5.51M12.75M9.83M9.47M43.16M
EV to EBITDA-3.58-2.57-1.78-1.26-4.27
EV to Sales0.630.670.630.9811.20
EV to Free Cash Flow-0.73-1.25-2.14-7.24-76.21
EV to Operating Cash Flow-0.87-2.09-4.90-11.70-648.66
Tangible Book Value Per Share0.01-0.08-0.040.09-0.01
Shareholders’ Equity Per Share0.01-0.07-0.020.100.01
Tax and Other Ratios
Effective Tax Rate-0.010.110.010.030.04
Revenue Per Share0.030.220.180.120.07
Net Income Per Share0.03-0.08-0.08-0.09-0.19
Tax Burden-2.970.891.010.950.96
Interest Burden1.051.211.061.021.00
Research & Development to Revenue0.000.000.020.060.03
SG&A to Revenue1.090.910.460.850.95
Stock-Based Compensation to Revenue0.000.030.070.260.22
Income Quality-0.850.920.290.080.49

Currency in CAD